Interview | WAMJ UPDATE | Page 17 of 24

Joseph P. McMenamin, MD, JD, FCLM

Please introduce your current profession in the clinical and/or non-clinical setting. What experiences have motivated you to pursue your...

ISSUE 9

FROM THE PUBLISHER Dear Colleagues, Hope your spring is going well. In this issue, we feature a round table interview of three physicians...

Issue8

October 2015 - November 2015 FDA Approves Two New Drug Treatments for Diabetes Mellitus According to the Centers for Disease Control and...

Dr. David H. Song, the President of the American Society of Plastic Surgeons

Dr. Song, you are world-renowned successful plastic surgeon. What was your motivation to become a doctor and did you face any significant...

Controlling Drug Prices

Biopharmaceutical Report III Goodwill Hunting Martin Shkreli and Hillary Clinton last week provided the flint and steel that ignited a...

AbbVie’s Combination Drug for Hepatitis C has Elicited Mixed Expert Opinions

• Success in vitro foreshadows pan-genotypic success • Six HCV genotypes have unique viral dynamics • Drug should be bearable for...

No Differentiation Expected Among PARP Inhibitors

PARP inhibitors like Tesaro’s (NASDAQ:TSRO) niraparib, Clovis Oncology’s (NASDAQ:CLVS) rucaparib and AstraZeneca’s (LON:AZN) approved...

Issue8

North America International conference and exhibition on Cosmetic Dermatology and Hair Care December 07-08, 2015 Philadelphia, USA...

WKMO Fall Concert 2015

A special WKMO Gala took place on October 31, 2015, in Palisades, New York! Organized and sponsored by World Korean Medical Organization...

Biotech Company Launches New Global Initiative

Korea’s leading Sohn biopharmaceutical company Enzychem Lifesciences (CEO and Chairman SOHN Ki-Young) has launched its major global...

Subscribe to Our Journal